Abstract
The Ru(II)-nitrite complex, Ru4, is explored to release nitric oxide (NO) under acidic conditions and selectively induce a cytotoxic effect towards SK-MEL-28 cisplatin-resistant malignant melanoma cells. These findings suggest that targeting the tumor-associated pHe level could be an effective strategy for the drug function of Ru(II)-nitrite compounds.
MeSH terms
-
Antineoplastic Agents* / chemical synthesis
-
Antineoplastic Agents* / chemistry
-
Antineoplastic Agents* / pharmacology
-
Cell Death / drug effects
-
Cell Line, Tumor
-
Cisplatin* / chemistry
-
Cisplatin* / pharmacology
-
Coordination Complexes* / chemical synthesis
-
Coordination Complexes* / chemistry
-
Coordination Complexes* / pharmacology
-
Cymenes* / chemistry
-
Cymenes* / pharmacology
-
Drug Resistance, Neoplasm* / drug effects
-
Humans
-
Melanoma* / drug therapy
-
Melanoma* / metabolism
-
Melanoma* / pathology
-
Monoterpenes / chemistry
-
Monoterpenes / pharmacology
-
Nitric Oxide* / metabolism
-
Nitrites* / chemistry
-
Nitrites* / pharmacology
-
Ruthenium* / chemistry
-
Ruthenium* / pharmacology
Substances
-
Cisplatin
-
Ruthenium
-
Antineoplastic Agents
-
Cymenes
-
Nitrites
-
Coordination Complexes
-
4-cymene
-
Nitric Oxide
-
Monoterpenes